EXHIBIT 11.0 MEDQUIST INC. EARNINGS PER SHARE CALCULATION FOR THE YEAR ENDED DECEMBER 31, 1995 Net income from continuing operations as reported................................. $607,000 Interest effect: Excess proceeds applied to reduce debt.......................................... 6,751,000 (A) Effective annual interest rate.................................................. 10.00%(1) ----------- Annual interst savings.......................................................... 675,100 Tax rate........................................................................ 40.00% ----------- Adjustment to net income for interest savings, net of tax effect.................. 405,000 ------------- ADJUSTED NET INCOME USED IN EARNINGS PER SHARE.................................... $1,012,000 ------------- Weighted average shares outstanding............................................... 2,362,000 ------------- Total options and warrants outstanding.......................................... 1,624,000 Less: 20% share repurchase limit................................................ 652,000(2) ----------- Dilutive options and warrants..................................................... 973,000 SHARES USED IN COMPUTING EARNINGS PER SHARE....................................... 3,335,000 ------------- EARNINGS PER SHARE................................................................ $0.30 ------------- Total proceeds from exercise of warrants and options, net of tax benefit.......... 11,841,000 ------------- 20% share of repurchase limit................................................... 652,000(2) Average fair market value per share............................................. $7.81(3) ----------- Less: proceeds used to repurchase shares.......................................... (5,090,000) Excess proceeds applied to reduce debt............................................ 6,751,000(A) ------------- ------------------ (1) Effective interest rate of senior subordinated debt. (2) APB No. 15 limits share repurchase to 20% of common stock outstanding at the end of the period. See footnote 1 of notes to the consolidated financial statements. (3) Average closing market price of stock during the year ended December 31, 1995. Exhibit 11.0